Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with rectal cancer that has spread to nearby tissues or lymph nodes but can still be surgically removed, confirmed by a tissue sample (biopsy)
- People who received treatment (such as chemotherapy or radiation) before their surgery
- People who have had complete surgical removal of their rectal cancer followed by examination of the removed tissue in a laboratory
- People who have been fully informed about the trial and have signed a consent form agreeing to take part
Who may not be able to join:
- People whose medical scan images are of poor quality, for example due to significant distortion or interference in the images
- People who have complications such as a blocked or perforated bowel that require urgent surgery
- People whose pre-surgery MRI scan was taken more than 2 weeks before their operation
- People who received any prior treatment for rectal cancer before the treatment described in this trial
- People who have a history of any other type of cancer
- People who are unable to have an MRI scan due to medical reasons that make MRI unsafe or inadvisable (confirm with trial site)
- People who were lost to follow-up or chose to withdraw from the study due to side effects or other reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86+13724071514
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
the area under curve (AUC) of receiver operating characteristic (ROC) curves of models in prediction tumor response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.